Conclusions & Recommendations
26.4.1 - TEC suggested the following agenda items for the TEC 28 meeting
Conclusion/Recommendation:
TEC requests a presentation from national program managers on how they use coverage tools (and other program tools) during the TEC 28 meeting
Action:
The program managers from Kenya and Tanzania will be present at TEC 28 to present on program tools.
TEC 26
2022
TEC meeting management
26.4.2 - TEC suggested the following agenda items for the TEC 28 meeting
Conclusion/Recommendation:
Reports from the national programs in the first 6 countries implementing modified strategies on their experience, ideally including information on key indicators comparing pre-modified to post-modified implementation. Examples may include: increase in the number of supervisors from X to Y; increase in the number of treatments from X to Y; measures from BCC strategies. TEC recommends supporting NPCs during the ITI-supported Regional Meetings to identify a useful common set of indicators to be reported on in the future.
Action:
ITI is working with national programs to share lessons learned during the early phases of implementation at TEC 28 (and 29). Suggested indicators have been suggested through presentation templates provided to national programs.
TEC 26
2022
alternative treatment strategies
25.1.1 - To ITI Management
Conclusion/Recommendation:
TEC recommends a letter of appreciation be sent by ITI Management on behalf of TEC to the EFDA, thanking the Ethiopian government for their flexibility in accepting near-expiry POS
Action:
A letter of appreciation was presented to the Federal Minister of Health by the TEC Chair in February 2022.
TEC 25
2021
Africa - East
Ethiopia
recommendations for ITI management
25.1.2 - To ITI Management
Conclusion/Recommendation:
TEC accepted the revisions to the Charter as presented, and ITI will share the final version (flagging any additional changes) once Pfizer has formally agreed to the edits.
Action:
The Charter is with Pfizer, pending formal confirmation of agreement.
TEC 25
2021
recommendations for ITI management
25.1.3 - To ITI Management
Conclusion/Recommendation:
TEC recommends that ITI Management share key guidelines for participation at TEC meetings (as outlined in the revised TEC Charter) with Observers as a part of future meeting invitations
Action:
Once the Charter is back from Pfizer, ITI will share it with Observers.
TEC 25
2021
recommendations for ITI management, TEC meeting management
25.1.4 - To ITI Management
Conclusion/Recommendation:
TEC notes with cautious optimism the careful continuation of MDA in the midst of COVID.
Action:
No action required
TEC 25
2021
COVID
25.1.5 - To ITI Management
Conclusion/Recommendation:
TEC appreciates ITI’s development of the new TEC Recommendation Tracker.
Action:
No action required
TEC 25
2021
recommendations for ITI management
25.1.6 - To ITI Management
Conclusion/Recommendation:
TEC, ITI, and Pfizer discussed holding an appropriate celebration of the billionth dose of Zithromax® donated. Given that the manufacturing facilities are now third party owned, ELC is not an ideal venue for a celebration, and anticipated continued travel constraints in Q1 2022, suggested options included: Atlanta; Washington, D.C.; or a country nearing elimination, held later in 2022 when travel may become easier. Additional discussions exploring these and other options will be held in the coming months.
Action:
TEC will continue to discuss options during the TEC 26 and TEC 27 meetings.
TEC 25
2021
recommendations for ITI management, TEC meeting management
25.2.1 - Country gaps
Conclusion/Recommendation:
TEC recommends a high-level visit from TEC Chair and ITI Director to Egypt to work out gaps in leadership leading to program delays (e.g., signing MOU; getting program financing into the country).
Action:
A partners meeting was held in Cairo in February 2022 with the ITI Senior Program Associate and Supply Chain Analyst in attendance. Groundwork was laid with the two newly appointed trachoma focal persons and a 2022 TEMF/2023 Zithromax® Application was submitted. A high-level visit may be most beneficial following the review of the application at TEC 27 to facilitate signature of an MOU.
TEC 25
2021
Eastern Mediterranean
Egypt
recommendations for ITI management
25.2.2 - Country gaps
Conclusion/Recommendation:
TEC recommends that TEC member Chad MacArthur follows up with partners and the national program in Fiji and Papua New Guinea to understand the current situation and determine whether there are any steps that could be taken to move the programs forward.
Action:
Chad MacArthur reached out to both programs:
- PNG's current focus is on COVID19. The trachoma program remains on hold awaiting guidance following implementation of the recommendations of the WPRO meeting. They completed an ancillary survey in January 2020, the results of which showed little presence of Herbert's pits and pannus and mirrors the landscape of trachoma in many of the Pacific Island countries.
- Fiji has had a number of setbacks due to natural disasters, disease outbreaks, and the COVID response. Baseline surveys for the remaining 32 EUs began in February 2022, and results will guide the need for MDA.
TEC 25
2021
Western Pacific
Fiji, Papua New Guinea
recommendations for ITI management